Hims & Hers Health, Inc. EV/OCF LTM
| Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|
| EV/OCF LTM | (5.3x) | (84.2x) | (32.7x) | (49.3x) | 37.5x |
Hims & Hers Health, Inc. (HIMS) EV/OCF LTM comparison analysis
General
LTM EV/OCF LTM
OTHER METRICS
Company name
Revenue growth
EPS growth
Net Income margin
HIMS key stats
| Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|
% growth | 26.7 0.0% | 82.6 209.4% | 148.8 80.2% | 271.9 82.8% | 526.9 93.8% | 872.0 65.5% |
| Cost of Goods Sold (COGS) | 18.9 | 38.0 | 39.3 | 67.4 | 118.2 | 157.1 |
% margin | 7.8 29.2% | 44.6 54.0% | 109.5 73.6% | 204.5 75.2% | 408.7 77.6% | 714.9 82.0% |
| Operating Expenses | 83.6 | 119.0 | 124.6 | 319.5 | 477.4 | 744.4 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 11.2 | 22.4 | 29.2 | 48.2 |
| Selling, General & Administrative Expenses (SG&A) | 83.6 | 119.0 | 124.6 | 319.5 | 370.8 | 692.7 |
% margin | (75.8) (284.0%) | (74.4) (90.1%) | (15.1) (10.2%) | (115.0) (42.3%) | (68.7) (13.0%) | (29.5) (3.4%) |
| Interest Income | 0.6 | 1.9 | 0.4 | 0.4 | 2.6 | 0.0 |
| Interest Expense | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 |
| Pre-tax Income | (75.2) | (72.0) | (18.0) | (110.8) | (65.7) | (21.6) |
% effective tax rate | 0.0 (0.0%) | 0.1 (0.1%) | 0.1 (0.7%) | (3.1) 2.8% | (0.0) 0.0% | 2.0 (9.2%) |
% margin | (75.2) (282.0%) | (72.1) (87.3%) | (18.1) (12.2%) | (107.7) (39.6%) | (65.7) (12.5%) | (23.5) (2.7%) |
| EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
| Diluted EPS | (1.12) | (2.86) | (0.51) | (0.58) | (0.32) | (0.11) |
% margin | 0.0 0.0% | (74.2) (89.8%) | (14.1) (9.5%) | (111.0) (40.8%) | (61.2) (11.6%) | (19.9) (2.3%) |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
FAQ
1) What is Hims & Hers Health, Inc.'s EV/OCF LTM?
As of today, Microsoft Corp's last 12-month EV/OCF LTM is 27.6x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual EV/OCF LTM for Hims & Hers Health, Inc. have been 33.9x over the past three years, and (16.9x) over the past five years.
2) Is Hims & Hers Health, Inc.'s EV/OCF LTM Good?
As of today, Hims & Hers Health, Inc.'s EV/OCF LTM is 27.6x, which is higher than industry median of 15.9x. It indicates that Hims & Hers Health, Inc.'s EV/OCF LTM is Bad.